Selective cardioneuroablation targeting the posteromedial left ganglionated plexus may eliminate syncopal episodes in young patients with swallow syncope and functional atrioventricular block.
Case Report
Does selective cardioneuroablation of the posteromedial left ganglionated plexus prevent syncopal episodes in patients with drug-resistant swallow syncope and functional atrioventricular block?
Selective cardioneuroablation of the posteromedial left ganglionated plexus may serve as an effective alternative to pacemaker implantation for young patients with drug-resistant swallow syncope and functional AV block.
Key Teaching Points•Although pacemaker implantation is a well-established therapy for swallow syncope, it is generally deemed inappropriate for young patients (aged 60 beats/min) at the time of functional AV block, minimal cardioneuroablation selectively targeting the posteromedial left GP may be sufficient to eliminate syncopal episodes. •Although pacemaker implantation is a well-established therapy for swallow syncope, it is generally deemed inappropriate for young patients (aged 60 beats/min) at the time of functional AV block, minimal cardioneuroablation selectively targeting the posteromedial left GP may be sufficient to eliminate syncopal episodes.
Yoneda et al. (Thu,) conducted a case report in Drug-resistant swallow syncope with functional atrioventricular block. Selective cardioneuroablation of the posteromedial left ganglionated plexus was evaluated. Selective cardioneuroablation targeting the posteromedial left ganglionated plexus may eliminate syncopal episodes in young patients with swallow syncope and functional atrioventricular block.